|
1
|
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
|
Nat Med
|
2005
|
6.50
|
|
2
|
p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes.
|
Genes Dev
|
2005
|
3.88
|
|
3
|
Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.
|
J Clin Invest
|
2005
|
3.22
|
|
4
|
Macrophage deletion of p38alpha partially impairs lipopolysaccharide-induced cellular activation.
|
J Immunol
|
2008
|
1.68
|
|
5
|
Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers.
|
Int J Cancer
|
2004
|
1.60
|
|
6
|
A novel mitochondrial matrix serine/threonine protein phosphatase regulates the mitochondria permeability transition pore and is essential for cellular survival and development.
|
Genes Dev
|
2007
|
1.49
|
|
7
|
Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts.
|
Circ Res
|
2011
|
1.41
|
|
8
|
An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria.
|
Hum Mol Genet
|
2010
|
1.26
|
|
9
|
Inducible and cardiac specific PTEN inactivation protects ischemia/reperfusion injury.
|
J Mol Cell Cardiol
|
2008
|
1.25
|
|
10
|
Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.
|
Development
|
2012
|
1.21
|
|
11
|
MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
|
Circ Res
|
2010
|
1.12
|
|
12
|
Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth.
|
J Biol Chem
|
2006
|
1.12
|
|
13
|
Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin.
|
Hum Mol Genet
|
2010
|
1.09
|
|
14
|
Quantitative analysis of the chromatin proteome in disease reveals remodeling principles and identifies high mobility group protein B2 as a regulator of hypertrophic growth.
|
Mol Cell Proteomics
|
2012
|
1.03
|
|
15
|
Gi-biased β2AR signaling links GRK2 upregulation to heart failure.
|
Circ Res
|
2011
|
1.01
|
|
16
|
Gi alpha 1-mediated cardiac electrophysiological remodeling and arrhythmia in hypertrophic cardiomyopathy.
|
Circulation
|
2007
|
0.93
|
|
17
|
Catabolism of branched-chain amino acids in heart failure: insights from genetic models.
|
Pediatr Cardiol
|
2011
|
0.92
|
|
18
|
Loss of Bmx nonreceptor tyrosine kinase prevents pressure overload-induced cardiac hypertrophy.
|
Circ Res
|
2008
|
0.91
|
|
19
|
Conditional over-expression of estrogen receptor alpha in a transgenic mouse model.
|
Transgenic Res
|
2002
|
0.90
|
|
20
|
PPM1l encodes an inositol requiring-protein 1 (IRE1) specific phosphatase that regulates the functional outcome of the ER stress response.
|
Mol Metab
|
2013
|
0.90
|
|
21
|
RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure.
|
J Clin Invest
|
2015
|
0.84
|
|
22
|
Systems proteomics of cardiac chromatin identifies nucleolin as a regulator of growth and cellular plasticity in cardiomyocytes.
|
Am J Physiol Heart Circ Physiol
|
2013
|
0.82
|
|
23
|
Post-translational regulation of calsarcin-1 during pressure overload-induced cardiac hypertrophy.
|
J Mol Cell Cardiol
|
2010
|
0.81
|
|
24
|
Concurrent pregnancy retards mammary involution: effects on apoptosis and proliferation of the mammary epithelium after forced weaning of mice.
|
Biol Reprod
|
2002
|
0.78
|
|
25
|
Chemoprevention of mammary carcinogenesis in a transgenic mouse model by alpha-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity.
|
Oncogene
|
2003
|
0.77
|